Skip to main content

Table 4 Response to OnabotA

From: CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA

  No (n) Yes (n)
rs145837941 (CALCA)
 AA 18 63
 AG 0 0
 GG 0 0
rs1800497 (DRD2)
 AA 1 2
 AG 7 25
 GG 15 38
rs2201169 (GABRA3)
 TT 28 80
 TC 8 38
 CC 0 2
rs1139916 (GABRE)
 AA 6 10
 CA 14 57
 CC 16 53
rs6691840 (GRIK3)
 AA 23 66
 AC 13 43
 CC 0 9
rs734784 (KCNS1)
 GG 8 29
 GA 14 56
 AA 13 34
rs1050316 (MEF2D)
 TT 16 51
 TG 17 56
 GG 3 13
rs121434294 (MTHFR)
 CC 19 68
 CT 0 0
 TT 0 0
rs2230912 (P2RX7)
 AA 27 85
 AG 8 28
 GG 1 3
rs7640543 (TGFBR2)
 AA 4 11
 AG 17 60
 GG 15 49
rs222741 (TRPV1)
 TT 18 64
 TC 15 51
 CC 2 5
rs222749 (TRPV1)
 AA 3 1
 GA 3 8
 GG 30 111
rs734312 (WFS1)
 AA 12 34
 AG 14 55
 GG 9 31
rs3781719 (CALCA)
 TT 9 63
 TC 21 45
 CC 3 9
rs4354668 (EAAT2)
 GG 3 22
 GT 16 54
 TT 17 43
rs6627221 (GABRA3)
 CC 1 3
 CT 8 44
 TT 27 73
rs3810651 (GABRQ)
 TT 7 19
 TA 17 55
 AA 11 42
rs3813929_1732 (HTR2C)
 TT 1 2
 CT 15 35
 CC 20 82
rs11172113 (LRP1)
 CC 4 13
 CT 18 49
 TT 14 58
rs1835740 (MTDH)
 GG 24 73
 GA 10 43
 AA 2 4
rs1718119 (P2RX7)
 TT 3 17
 TC 16 47
 CC 17 55
rs6746030 (SCN9A)
 GG 29 88
 AG 6 30
 AA 1 1
rs10166942 (TRPM8)
 TT 25 85
 TC 9 32
 CC 2 3
rs222747 (TRPV1)
 GG 21 70
 GC 12 43
 CC 3 6
rs7217270 (TRPV3)
 AA 9 21
 AG 16 54
 GG 11 45
\